Home NDC 63323-315
Ganciclovir
Product NDC 63323-315
11-digit product format 633230315
Labeler code 63323
Product ID 63323-315_41a1504e-f02c-4ec1-9650-709e945234eb
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name GANCICLOVIR SODIUM
Dosage form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route INTRAVENOUS
Labeler Fresenius Kabi USA, LLC
Application ANDA090658
Marketing category ANDA
Marketing start 2010-06-28
Substance GANCICLOVIR SODIUM
Active strength 500 mg/10mL
Pharmacologic classes Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], DNA Polymerase Inhibitors [MoA], Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Additional Listing Data#
Finished product Yes
Brand name base Ganciclovir
Listing expiration 2027-12-31
Active Ingredients# Ingredient, Strength table Ingredient Strength GANCICLOVIR SODIUM 500 mg/10mL
Harmonized Identifiers# Field, Values table Field Values Unii 02L083W284 Rxcui 310442
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 63323-315-01 Ganciclovir 10 mL in 1 VIAL INJECTION, POWDER, LYOPHILIZED, 10 8 63323-315-10 Ganciclovir 25 in 1 TRAY INJECTION, POWDER, LYOPHILIZED, 25 8 63323-315-41 Ganciclovir 10 mL in 1 VIAL INJECTION, POWDER, LYOPHILIZED, 10 6 63323-315-94 Ganciclovir 25 in 1 TRAY INJECTION, POWDER, LYOPHILIZED, 25 6
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded GANCICLOVIR SODIUM ACTIVE INGREDIENT 02L083W284 GANCICLOVIR (GANCICLOVIR SODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC] 2 GANCICLOVIR ACTIVE MOIETY P9G3CKZ4P5 GANCICLOVIR (GANCICLOVIR SODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC] 2 GANCICLOVIR SODIUM ACTIVE INGREDIENT 02L083W284 GANCICLOVIR (GANCICLOVIR SODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [APP PHARMACEUTICALS, LLC] 1 GANCICLOVIR ACTIVE MOIETY P9G3CKZ4P5 GANCICLOVIR (GANCICLOVIR SODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [APP PHARMACEUTICALS, LLC] 1
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 63323-315 GANCICLOVIR (GANCICLOVIR SODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC
] 7 Current NDC, Legacy NDC, 2 package rows 20221203_b47f5d1c-36b8-49b6-a410-3b3f4661dde7.zip 63323-315 GANCICLOVIR (GANCICLOVIR SODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC
] 5 Current NDC, Legacy NDC, 2 package rows 20230115_35addab5-09db-4f8a-9c69-6fbce33ecc37.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 63323-315-01 63323031501 10 mL in 1 VIAL 10 ml Historical 63323-315-10 63323031510 25 VIAL in 1 TRAY (63323-315-10) / 10 mL in 1 VIAL (63323-315-01) 25 vial 2010-06-28 0000-00-00 No No Current 63323-315-41 63323031541 10 mL in 1 VIAL 10 ml Historical 63323-315-94 63323031594 25 VIAL in 1 TRAY (63323-315-94) / 10 mL in 1 VIAL (63323-315-41) 25 vial 2010-06-28 0000-00-00 No No Current